The effect of two methods of transcutaneous supraorbital nerve stimulation and transcutaneous infraorbital nerve stimulation in improving clinical symptoms in patients with migraine

Not Applicable

Recruiting

• Conditions: Migraine.; Migraine, unspecified, not intractable, without status migrainosus; G43.909

• Registration Number: IRCT20200825048515N37
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 81

Inclusion Criteria

Age category above 18 and under 65 years
Patients with migraine

Exclusion Criteria

Use of migraine prevention in the last two weeks
Use of migraine prevention methods such as nerve block, Botox injection, etc. in the previous year
Headache due to overdose medication
Having severe psychiatric illnesses or physical disorders
Having other types of headaches (such as tension and clustering)
Pregnancy and lactation
Opioid use
Failure to complete treatment sessions

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Migraine severity. Timepoint: Before the intervention and three months after the intervention. Method of measurement: Questionnare of Headache Impact Test 6 score (HIT-6).;Disability score in a person's life. Timepoint: Before the intervention, 1 and 3 months after the intervention. Method of measurement: Migrain disability assessment test (MIDAS).;Pain. Timepoint: Before the intervention, 1 and 3 months after the intervention. Method of measurement: Visual Analog Scale (VAS).